 |
|
|
| Internet Search |
|
Stock Search |
|
|
|
|
|
EPIMMUNE INC, (EPMN) Stock Research Free Stock Rating
|
|
| |
| Company Profile |
| |
|
Epimmune, Inc., a biopharmaceutical company, engages in the development of therapeutic and preventative vaccine solutions, services, and other products. The company is developing therapeutic vaccine drug candidates for the treatment of diseases, such as HIV; hepatitis C; Papilloma virus and hepatitis B virus; and tumors, which include breast, colon, lung, and prostate. It is also developing prophylactic vaccine drug candidates for treating disease, such as HIV, Malaxia, and Hepatitis C. In addition, the company is developing Ex Vivo Immunotherapy for various solid tumours. It has collaboration agreements with Bavarian Nordic A/S; Innogenetics N.V.; and Valentis, Inc. The company is based in San Diego, California.
|
EPIMMUNE INC Related |
|
Epimmune, Inc. Company Profile | Company Information Epimmune, Inc. Company Profile - View Epimmune, Inc. Company Information. Financial information, key executives, company news and more.
|
|
BioSpace - Epimmune Inc. News, Search Jobs, Events Epimmune Inc. 5820 Nancy Ridge Drive, Suite 200. San Diego California ... Epimmune Inc. ( EPMN) Reports 2004 Financial Results 10/19/2005 5:13:07 PM More...
|
|
Summary of EPIMMUNE INC - Yahoo! Finance On July 1, 1999, Cytel merged with its majority-owned subsidiary, Epimmune Inc., and changed its name from Cytel Corporation to Epimmune Inc. ...
|
|
|
|
|
